Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Amongst children with multiple sclerosis (MS) there is a higher prevalence of the condition in girls, according to research from doctors at the Shanghai Xin Hua Hospital. The doctors used information...
UK scientists are to investigate whether wearable robots could help people with multiple sclerosis (MS) get more exercise. Dr Siva Nair and his team at Royal Hallamshire Hospital in Sheffield will...
On Tuesday 03 December, the Essex Neurology Network in partnership with Healthwatch Essex have launched an e-learning tool for health and social care professionals. The tool, ‘Understanding Neurology...
A new study has found further evidence that changes to the gut microbiome play a role in the development of multiple sclerosis (MS). Scientists at the New York School of Medicine found that newly...
Scientists have moved a step closer to blocking the progression of multiple sclerosis (MS) by lessening the flow of B-cells into the brain, according to a new study. In a healthy brain, the blood-...
New research has found that an investigational targeted therapy called CD45-ADC can reset the normal function of the immune system in a mouse model of multiple sclerosis (MS). CD45-ADC is an antibody...
The Personal Independence Payment (PIP) application process is ‘humiliating and degrading’ and is ‘cheating people with multiple sclerosis (MS) out of vital support’, according to new research by the...
A new study from the University Of Virginia School Of Medicine has discovered that oligodendrocyte progenitor cells are key contributors to the development of multiple sclerosis (MS). These cells are...
Today is Purple Tuesday, an international call to action to customer-facing businesses to put accessibility at the forefront of their company. Coordinated by Purple, a disability organisation, the...
Medical cannabis has been approved for use on the NHS in England for people with multiple sclerosis (MS) for the first time. The National Institute for Health and Care Excellence (NICE) has given the...

Pages